抄録
Rhythm control therapy by sodium channel blockers is widely performed for the treatment of paroxysmal atrial fibrillation. Here, we present a case of acquired Brugada syndrome by pill-in-the-pocket treatment using pilsicainide. It is important that this therapy should be applied only after confirming the drug safety to the patients.
本文言語 | English |
---|---|
ページ(範囲) | 139-140 |
ページ数 | 2 |
ジャーナル | Drug, Healthcare and Patient Safety |
巻 | 2 |
号 | 1 |
DOI | |
出版ステータス | Published - 2010 |
ASJC Scopus subject areas
- 薬理学
- 健康政策